Prostate Cancer News on BioPortfolio

Nuclear gatekeeper could block undruggable prostate cancer targets

Certain molecular drivers of cancer growth are "undruggable" it's been nearly impossible to develop chemicals that would block their action and prevent cancer growth.Many of these molecules function by passing cancerpromoting information through...

Common skin cancer can signal increased risk of other cancers

People who develop abnormally frequent cases of a skin cancer known as basal cell carcinoma appear to be at significantly increased risk for the development of other cancers including blood breast colon and prostate cancers according to a preliminary...

Nanoparticle therapy could deliver double blow to cancer

University of East Anglia A new cancer therapy using nanoparticles to deliver a combination therapy direct to cancer cells could be on the horizon.Using nanoparticles to get drugs directly into a tumor is a growing area of cancer research. The technology d...

Lumicell Launches Wound Care Infection and Perfusion Division

New business unit aims to tackle challenges around chronic wounds Lumicell Inc. a leader in the field of imageguided cancer surgeryÂtoday announced that it has created a new division to drive the expansion of its pioneering techn...

Nanjing Sanpower Transfers Dendreon to Cenbest for $868 Million

Nanjing Sanpower a major China conglomerate has "sold" its Dendreon pharmaceutical subsidiary by transferring Dendreon to another of Sanpower's holdings the China retail company Cenbest in exchange for $868 million of stock. One year ago Sanpower...

Pages